Tumor-Targeting Anti-CD20 Antibodies Mediate In Vitro Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and In Vivo Priming.
about
Tumor-Targeting Anti-CD20 Antibodies Mediate In Vitro Expansion of Memory Natural Killer Cells: Impact of CD16 Affinity Ligation Conditions and In Vivo Priming.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Tumor-Targeting Anti-CD20 Anti ...... onditions and In Vivo Priming.
@en
Tumor-Targeting Anti-CD20 Anti ...... onditions and In Vivo Priming.
@nl
type
label
Tumor-Targeting Anti-CD20 Anti ...... onditions and In Vivo Priming.
@en
Tumor-Targeting Anti-CD20 Anti ...... onditions and In Vivo Priming.
@nl
prefLabel
Tumor-Targeting Anti-CD20 Anti ...... onditions and In Vivo Priming.
@en
Tumor-Targeting Anti-CD20 Anti ...... onditions and In Vivo Priming.
@nl
P2093
P2860
P356
P1476
Tumor-Targeting Anti-CD20 Anti ...... onditions and In Vivo Priming.
@en
P2093
Angela Santoni
Chiara Pighi
Cristina Capuano
Gabriella Palmieri
Lavinia Franchitti
Ombretta Turriziani
Ricciarda Galandrini
Simone Battella
Stefania Morrone
P2860
P356
10.3389/FIMMU.2018.01031
P577
2018-05-11T00:00:00Z